Annual Drug Patent Expirations for LIVMARLI
Livmarli is a drug marketed by Mirum and is included in one NDA. There are three patents protecting this drug.
This drug has one hundred patent family members in eighteen countries.
The generic ingredient in LIVMARLI is maralixibat chloride. Additional details are available on the maralixibat chloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
